Legal Representation
Attorney
Carlynn Ferguson
USPTO Deadlines
Next Deadline
476 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-10-27)
Due Date
October 27, 2026
Grace Period Ends
April 27, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 eventsDate | Code | Type | Description |
---|---|---|---|
Jan 21, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Apr 4, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
Feb 11, 2021 | XXCR | P | GENERIC MADRID TRANSACTION CREATED |
Feb 11, 2021 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB |
Jan 27, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Oct 27, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Aug 11, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
Aug 11, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Aug 7, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB |
Jul 22, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jul 22, 2020 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Jul 22, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Jul 7, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Jul 7, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Jul 7, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Jul 7, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Jul 7, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jul 6, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jul 6, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jul 6, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Feb 8, 2020 | RFNT | P | REFUSAL PROCESSED BY IB |
Jan 21, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU |
Jan 21, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Dec 12, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Dec 11, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 11, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
Dec 10, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Dec 6, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Dec 5, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; syringes sold prefilled with pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders, and intravenous analgesics and antipyretics
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; medical device, namely, medical syringes used for manual injection
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010